How do we address acute bacterial skin and skin structure infections (ABSSSIs) when the IDSA practice guidelines are more than 10 years old? Listen in as experts Thomas P. Lodise, PharmD, PhD, and George Sakoulas, MD, FIDSA, discuss tailored antibiotic strategies for diverse patients, focusing on antibiotic developments that have come since the publication of the IDSA practice guidelines in 2014.

Learn to look beyond viral suppression with Brian Wood, MD, and Cristina Mussini, MD, and find out how people living with virologically suppressed HIV can still be candidates for ART switch to improve treatment satisfaction and quality of life.

Join Ryan K. Shields, PharmD, MS, in the third of 3 recap podcasts taken from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. This episode covers the most recent updates on evolving treatment paradigms for S. maltophilia.

Join Marin H. Kollef, MD in the first of 3 recap podcasts taken from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. This episode covers reassessment of carbapenemases and antibiotic selection.

Join Ryan K. Shields, PharmD, MS, in the second of 3 recap podcasts taken from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. This episode covers strategies for overcoming diverse antibiotic resistance profiles in DTR-P. aeruginosa.

Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal ART regimen for them. Stream this podcast to listen as Dima Dandachi, MD, MPH, FIDSA, FACP, and Chloe Orkin, MBChB, FRCP, MD, discuss key guideline recommendations regarding ART switch and reassuring clinical data regarding efficacy, tolerability, and quality of life associated with switching a suppressive ART regimen.

Rapid phenotypic antimicrobial susceptibility testing significantly reduces time to actionable results and can improve antibiotic decision-making for patients with bloodstream infections. Listen in to learn from Michael P. Veve, PharmD, MPH, how to optimally integrate rapid phenotypic AST into clinical practice, including incorporation into your existing antimicrobial stewardship workflow.

Unnecessary broad-spectrum antibiotics can drive antimicrobial resistance and cause adverse events, whereas inadequate antibiotic coverage is linked to increased mortality and length of stay for patients with bloodstream infections (BSIs). Listen now to learn from Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP), how to use rapid genotypic and phenotypic antimicrobial susceptibility testing results to inform antibiotic selection for patients with gram-negative BSIs.

Sepsis and bloodstream infections (BSIs) are common, causing millions of deaths each year. Tune in to learn from Jasmine R. Marcelin, MD, FACP, FIDSA, how inadequate antibiotic coverage can be linked to increased mortality and length of stay and how unnecessary broad-spectrum antibiotics can drive antimicrobial resistance.

Stream this podcast to learn from experts Tessa Rife-Pennington, PharmD, BCGP, and Frank North, PharmD, MPA, DPLA, DASPL, about how specialty pharmacists can apply practical strategies within different pharmacy settings to overcome barriers to PrEP use, especially among underserved patient subpopulations.

In this episode, expert patient navigators Shellye Jones and Lauren Jackson discuss the key take-home points of our online educational program on facilitating engagement in HIV care. Listen as they propose a framework for effectively retaining people in care.

Don’t settle! Listen in as Dr Monica Gandhi and Dr Luis Buzon Martin discuss how a proactive approach to ART switch can improve treatment satisfaction and quality of life for people living with virologically suppressed HIV.

Detectable HIV-1 RNA (viral load) can seem very worrisome for people living with HIV who are receiving antiretroviral therapy (ART) and for their healthcare professionals. Tune in to learn how Brian R. Wood, MD, differentiates HIV-1 RNA “blips” from persistent low-level viremia and from virologic failure and how he handles each scenario.

Tune into this podcast from Dr Clíona Ní Cheallaigh to learn strategies to provide person-centered care for treatment-experienced people with HIV, including ways to address each individual’s specific medical history and personal priorities.

In this podcast, expert faculty Atul Humar, MD, FRCP (C), and Camille Kotton, MD, FIDSA, FAST, take a deep dive into complex clinical scenarios and explore designing antiviral regimens for refractory cytomegalovirus (CMV) infections to minimize antiviral toxicities and maximize efficacy.

Stream now to learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections from expert faculty, Atul Humar, MD, FRCP (C).

Tune in to learn the fundamentals for timely identification of refractory cytomegalovirus (CMV) infections following solid organ transplantation from expert faculty, Camille Kotton, MD, FIDSA, FAST.

Listen in as Dr. Marcus Pereira and Dr. Raymund R. Razonable explore strategies for individualization of CMV management in high-risk kidney transplant recipients.

Listen in as Dr. Marcus Pereira and Dr. Raymund R. Razonable discuss the fundamentals of cytomegalovirus (CMV) in kidney transplant recipients, including the direct and indirect effects of CMV infection and patient risk factors.

Tune in to explore the role of rapid syndromic testing for gastrointestinal and joint infections and learn how to implement best practices in diagnostic and antimicrobial stewardship.